Reference:Cranshaw JH:Evans TW:Mitchell JA:,Br. J. Pharmacol.,2001,132,1699: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Reference | {{Reference | ||
|IDs= | |IDs= | ||
&&n.a.&& | &&n.a.&&LBF20115PG05 | ||
&&n.a.&& | &&n.a.&&LBF20207PG48 | ||
|pubmed=11309241 | |pubmed=11309241 | ||
|title=Characterization of the effects of isoprostanes on platelet aggregation in human whole blood | |title=Characterization of the effects of isoprostanes on platelet aggregation in human whole blood | ||
|doi= | |doi= | ||
}} | }} | ||
Latest revision as of 06:25, 9 June 2010
Details
If you newly created/edited a reference page, please click all authors' links to check their information.
- TITLE "Characterization of the effects of isoprostanes on platelet aggregation in human whole blood"
- PMID 11309241
- All journal titles
| Title | Characterization of the effects of isoprostanes on platelet aggregation in human whole blood |
| Author(s) | (Click a name to see records for each author.) |
| Journal | British Journal of Pharmacology (10 pages) |
| Year | 2001 |
| Volume | 132 |
| Page | 1699 |
| IDs and Links | |
|---|---|
| Search | |
| Google Scholar | |
Metabolite information in this article
| Reported Metabolites, References | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
